Sagespring Wealth Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98M Sell
10,218
-472
-4% -$200K 0.06% 149
2026
Q1
$5.06M Buy
10,690
+163
+2% +$82.1K 0.09% 111
2025
Q4
$4.91M Buy
10,527
+426
+4% +$198K 0.09% 111
2025
Q3
$4.31M Sell
10,101
-39
-0.4% -$15.1K 0.08% 116
2025
Q2
$3.88M Buy
10,140
+769
+8% +$277K 0.08% 121
2025
Q1
$3.24M Buy
9,371
+522
+6% +$168K 0.08% 117
2024
Q4
$2.66M Buy
+8,849
New +$3.09M 0.07% 118

Other funds holding HCA

Sagespring Wealth Partners's HCA Position: Q2 2026 in Review

Sagespring Wealth Partners reduced its HCA Healthcare (HCA) stake by 4.4% in Q2 2026, selling an estimated $200K and leaving 10,218 shares worth $3.98M. The position accounts for 0.06% of the portfolio, ranked #149.

Sagespring Wealth Partners first reported a position in HCA in Q4 2024 and has held it in 7 quarters since. The position peaked at $5.06M in Q1 2026. 1,340 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Sagespring Wealth Partners held 10,218 shares of HCA Healthcare worth $3.98M as of Q2 2026.
  • Sagespring Wealth Partners sold 472 HCA Healthcare shares in Q2 2026, an estimated $200K.
  • HCA Healthcare made up 0.06% of Sagespring Wealth Partners's portfolio in Q2 2026, its #149 holding.
  • Sagespring Wealth Partners first reported a position in HCA Healthcare in Q4 2024 and has held it in 7 quarters since.
  • Sagespring Wealth Partners's HCA Healthcare position peaked at $5.06M in Q1 2026.
  • 1,340 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Sagespring Wealth Partners's 13F filing for Q2 2026, filed 3 Aug 2026.